1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, August 2016

Biological Therapy Analysis & Statistics, August 2016

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

1-30 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016’, provides an overview of the Retinitis Pigmentosa ...

  • Industries : Therapy, Pathology, Research and Development, Biological Therapy
  • Countries : United States
Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Sangamo BioSciences, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sangamo BioSciences, ...

  • Industries : Research and Development, Biological Therapy, Therapy, Pathology
  • Countries : United States
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, ...

  • Industries : Pathology, Therapy, Pharmaceutical, Healthcare
  • Countries : United States
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, Therapy, Healthcare, Pharmaceutical
  • Countries : United States
Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016’, provides an overview of the Live ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Age Related Macular Degeneration - Pipeline Review, H1 2016

Age Related Macular Degeneration - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Age Related ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016’, provides an overview of ...

  • Industries : Therapy, Biopharmaceutical, Biological Therapy, Biotechnology
  • Countries : United States
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016’, provides an overview of the Metachromatic ...

  • Industries : Mental Health
  • Countries : United States, World
Stem Cell Banking Market by Bank Type, Service, Application, Region - Forecast to 2021

Stem Cell Banking Market by Bank Type, Service, Application, Region - Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global stem cell banking market is expected to reach USD 3.96 billion by 2021 from USD 1.58 billion in 2016, at a CAGR of 20.2% from 2016 to 2021. The storage services segment is expected to contribute ...

  • Industries : Biological Therapy, Biotechnology, Banking, Financial Services
  • Countries : World, North America
Regenerative Medicines Market by Therapy, Product, Application, Region - Global Forecast to 2021

Regenerative Medicines Market by Therapy, Product, Application, Region - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global regenerative medicines market is expected to reach USD 49.41 billion by 2021 from USD 17.06 billion in 2016, at a CAGR of 23.7% during the period of 2016-2021. The global regenerative medicines ...

  • Industries : Biological Therapy, Biotechnology, Genomics
  • Countries : World, Europe, North America
3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global 3D cell culture market size is expected to reach USD 1345.2 million by 2021 from USD 466.8 million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is segmented based on technology, ...

  • Industries : Biological Therapy, In Vitro Diagnostics, Biotechnology, Medical Device
  • Countries : World, North America, Europe
Cell Expansion Market by Product , Cell Type , Application , End user  - Global Forecasts to 2021

Cell Expansion Market by Product , Cell Type , Application , End user - Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World, Europe, Asia, North America
Trends in Gene Therapy

Trends in Gene Therapy

  • $ 5 000
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

The number of gene therapy products in preclinical to Phase III and beyond stages of development doubled between 2012 and 2015. Additionally, three gene therapy products have received regulatory approval ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : Europe, United States
US Market Report for Prostate Cancer Treatment Devices 2016 - MedCore

US Market Report for Prostate Cancer Treatment Devices 2016 - MedCore

  • $ 4 995
  • Industry report
  • July 2016
  • by iData Research, Inc.

Unlike other cancer treatments, brachytherapy has a history that spans over a century. In 1901, Pierre Curie, a physicist from France, first suggested that radiation could be used to treat cancer to one ...

  • Industries : Biological Therapy
  • Countries : United States
Global Laboratory  Reagents Industry

Global Laboratory  Reagents Industry

  • $ 4 950
  • Industry report
  • July 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Laboratory Chemical Reagents in US$ Thousand by the following Segments by Application Area: Molecular Biology (Monoclonal & Polyclonal Antibodies, Gene Expression, ...

  • Industries : Biotechnology, Genomics, In Vitro Diagnostics, Biological Therapy
  • Countries : World
Global Market Study on 3D Cell Culture: Asia to Witness Highest Growth by 2020

Global Market Study on 3D Cell Culture: Asia to Witness Highest Growth by 2020

  • $ 4 900
  • Industry report
  • August 2016
  • by Persistence Market Research

3D cell culture is a man-made environment which is created to allow cells to grow and interact with the surroundings in all three dimensions. It is an advanced cell culture technique that overcomes limitations ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World
Global Stem Cell Therapy Market Analysis & Trends - Industry Forecast to 2025

Global Stem Cell Therapy Market Analysis & Trends - Industry Forecast to 2025

  • $ 4 200
  • Industry report
  • June 2016
  • by Accuray Research LLP

The Global Stem Cell Therapy Market is poised to grow at a CAGR of around 37.3% over the next decade to reach approximately $1.87 billion by 2025. This industry report analyzes the global markets for Stem ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Macrophage Colony ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, World
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Granulocyte ...

  • Industries : Biological Therapy, Therapy, Pathology, Biotechnology, Cancer, Pharmaceutical
  • Countries : United States
Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Pipeline Review, H2 2016

Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like ...

  • Industries : Therapy, Biological Therapy, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States
Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016

Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States
Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, World, Europe
Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, ...

  • Industries : Biological Therapy, Therapy, Cancer, Pathology, Biopharmaceutical
  • Countries : Europe
65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) - Pipeline Review, H1 2016

65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology
  • Countries : United States, World
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin-1 or SMN1 or SMN2) - Pipeline Review, H1 2016

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin-1 or SMN1 or SMN2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin-1 or SMN1 or SMN2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Survival Motor Neuron Protein (Component Of Gems 1 or Gemin-1 ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States
Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016 Summary Global ...

  • Industries : Pathology, Therapy, Biological Therapy, Biotechnology
  • Countries : United States
Interleukin 7 Receptor Subunit Alpha (CD127 or IL7R) - Pipeline Review, H1 2016

Interleukin 7 Receptor Subunit Alpha (CD127 or IL7R) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 7 Receptor Subunit Alpha (CD127 or IL7R) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘ Interleukin 7 Receptor Subunit Alpha (CD127 or IL7R) - Pipeline Review, H1 2016’, ...

  • Industries : Biological Therapy, Therapy
  • Countries : United States, World, France
Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Pathology, Biopharmaceutical, Therapy, Biotechnology
  • Countries : World
Interleukin 15 (IL15) - Pipeline Review, H1 2016

Interleukin 15 (IL15) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 15 (IL15) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 15 (IL15) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 15 (IL15) targeted ...

  • Industries : Pathology, Biological Therapy, Therapy
  • Countries : World, United States
About 1 900 reports

Download Unlimited Documents from Trusted Public Sources

Hormone and Therapy Market in the UK

  • August 2016
    15 pages
  • Hormone  

    Therapy  

    Cytokine  

  • United Kingdom  

View report >

Dna Industry In Japan

August 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.